Researchers from the University of Illinois Chicago have discovered a new gene-editing technique that allows for the programming of sequential cuts — or edits — over time.

University of Missouri researchers develop a noninvasive way for identifying the major functions of the gastrointestinal tract.

When most people hear “food contamination,” they think of bacteria present on unwashed fruits or vegetables, or undercooked meat. However, there are other ways for harmful contaminants to be present in food products.

Qiagen announced the addition of kits for wastewater testing to its growing portfolio of Covid-19 products. The use of dPCR in the worldwide surveillance of Covid-19 is an additional step towards making digital PCR (dPCR) an affordable and standard instrument for a host of applications in molecular-testing laboratories worldwide.

The National University of Singapore (NUS) has developed a new range of strain sensors from Mxenes, a flexible, stretchable, and electrically conductive nanomaterial. The NUS is also exploring the application of these sensors in soft exoskeleton robots for rehabilitation and in surgical robots for transoral robotic surgery.

A laser-based sensor developed at Kaust could improve monitoring of benzene emissions and limit exposure to this pollutant. In collaboration with Saudi Aramco, the researchers have developed a device that accurately senses extremely low concentrations of benzene in real time.

Scientists at the Nottingham Trent University and Nottingham University Hospitals NHS Trust have identified a protein called sperm associated antigen 5 or Spag5 which if present in certain breast cancer patients indicates how they will respond to specific therapies.

Scientists and clinicians at the Nottingham Trent University and University Hospitals Leicester NHS Trust respectively have developed a new blood test which is capable of confirming whether a person has prostate cancer and if it is present, at what stage is it.

Scientists at the Global Center for Biomedical Science and Engineering have revealed that the molecular mechanism regulating the trafficking of lysosomes increases the invasiveness and metastasis of radioresistant cancer cells following radiotherapy.

A new study spearheaded by the Nottingham Trent University has helped clinicians to identify patients with aggressive leukaemia who will fail to respond to chemotherapy. The study will also assist in identifying patients that are most likely to benefit from a new immunotherapy.